Fig 1: EGR1 interacts with SRF and may regulate its activation on the Cd80 promoter(A) ChIP-seq enrichment profiles for H3K27Ac at the Cd80 locus were generated using WT or Egr1-/- BMDCs stimulated with LPS (100 ng/mL) and lactate (Lac, 20 mM) for 24 hr.(B) ChIP-seq enrichment profiles for EGR1 at the transcription start site (TSS) at the Cd80 locus were generated using WT BMDCs stimulated by LPS (100 ng/mL) and Lac (20 mM) for 24 hr.(C) The 3D protein structure of EGR1 and the EGR1 binding sequence from Protein DataBank were analyzed by CLC Genomics Workbench.(D) SRF was predicted as a potential transcription factor that binds to the region identified in (B) using TFBIND software. SRF was previously reported to interact with EGR1. TF, transcription factor.(E) ChIP-PCR analysis was performed using RAW 264.7 cells overexpressing Srf. ChIP was performed using control IgG (Ctrl) or anti-SRF antibody. PCR was performed using primers that detect sequences in the Cd80 promoter.(F) Co-immunoprecipitation experiments assessing EGR1 binding to SRF. Cell extracts from RAW 264.7 cells overexpressing both Srf and Myc-tagged Egr1 were immunoprecipitated with anti-SRF antibody or control IgG (Ctrl) and analyzed with anti-c-Myc and anti-SRF antibody by Western blotting.(G) Proposed schematic model of how lactate and its induction of EGR1 switches a hot tumor to a cold tumor. Lactate induces a shift from a hot tumor (presence of inflammation) to a cold (non-inflamed) tumor, while TLR4 ligands cause the opposite shift. Lactate upregulates the expression of EGR1, which may downregulate the expression of CD80.See also Figures S12–S14.
Supplier Page from OriGene Technologies for Srf (NM_020493) Mouse Untagged Clone